Physician profile
Lisa K Longhofer
NPI 1962662684
$4,799.42
in general payments reported to CMS, 2019-2025
18 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $679 · 2020: $466 · 2021: $256 · 2022: $520 · 2023: $2,430 · 2024: $197 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,222 · Travel and Lodging: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,221.65 |
| Travel and Lodging | $656.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $2,315.72 | 2023-2024 | |
| Anika Therapeutics, INC. | $734.05 | 2020-2024 | Tactoset, Integrity |
| Arthrosurface Incorporated | $692.91 | 2019-2025 | Speedspiral Cmc System, Wristmotion Wrist Hemiarthroplasty System |
| Revance Therapeutics, INC. | $148.50 | 2025 | Daxxify |
| Endo Pharmaceuticals INC. | $144.95 | 2019-2021 | |
| Rattan and Associates | $143.12 | 2019 | |
| Trice Medical, INC. | $96.75 | 2022 | |
| Depuy Synthes Sales INC. | $78.27 | 2020 | |
| Dynasplint Systems INC. | $67.68 | 2019 | |
| Baudax Bio INC. | $62.00 | 2021-2022 | |
| Arthrex, INC. | $61.54 | 2022 | |
| Integra Lifesciences Corporation | $54.10 | 2019-2021 | |
| Abbott Laboratories | $51.93 | 2022-2023 | Proclaim |
| Bioventus LLC | $42.59 | 2019 | |
| Zimmer Biomet Holdings, INC. | $36.62 | 2023 | Rosa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $35.18 | 2022 | |
| Smith+Nephew, INC. | $17.93 | 2022 | |
| Axogen | $15.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Longhofer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.